Mithra Signs Agreement for Commercialization of Myring™ in China with Abbott

 

Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it has entered into an exclusive license and commercialization agreement with Abbott for the registration and launch of its hormonal contraceptive ring Myring™ in China.

Under the terms of this agreement, Abbott will be responsible for the registration and commercialization of Mithra’s contraceptive vaginal ring in China. Moreover, Mithra will manufacture the product at its Contract Development and Manufacturing Organization (CDMO) facility in Belgium.

 

François Fornieri, CEO Mithra Women’s Health, comments: “We are extremely pleased to have successfully executed a first partnership with Abbott for the commercialization of Myring™ in China, the world's most populous country which present tremendous business opportunities for Mithra. We have also planned to meet all our potential partners in China during the largest economic mission ever organized by Belgium, which will be held in November under the chairmanship of HRH Princess Astrid. Abbott is a highly trusted partner with decade’s long experience in registration, launch and commercialization of pharmaceutical products in the field of women’s health.“

Note

Mithra (Euronext: MITRA) is dedicated to providing innovation and choice in Women’s Health, with a particular focus on contraception and menopause. Mithra’s goal is to develop new and improved products that meet women’s needs for better safety and convenience. Its three lead development candidates – a fifth generation oral contraceptive Estelle®, the first complete oral treatment for perimenopause PeriNesta® and next-generation hormone therapy Donesta® - are built on Mithra’s unique native estrogen platform, E4 (Estetrol). Mithra also develops and manufactures complex therapeutics and offers partners a complete spectrum of research, development and specialist  investors manufacturing at its CDMO. Mithra was founded in 1999 as a spin-off from the University of Liège by François Fornieri and Prof. Dr. Jean-Michel Foidart. Mithra is headquartered in Liège, Belgium. Further information can be found at www.mithra.com

 

 

Interested in a regular update of the Life Sciences and biotech sector in Flanders?